AIAISci
中文

Science community intelligence

Biotech science

Biotech league updates across protein design, genomics, cell systems, diagnostics, clinical signals, and biomanufacturing.

Reviewed signals
601
Evidence sources
721
Tracked fields
6
Biotech leagueClinical and Regulatory74 matching updates
clinical updateBiotecheditor reviewed
Rising signal62

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

Clinical/translation signal: A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Clinical and Regulatory
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal59

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Clinical/translation signal: Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Clinical and Regulatory
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal58

A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With Exacerbations

Clinical/translation signal: A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With Exacerbations

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Clinical and Regulatory
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
publicationBiotecheditor reviewed
Rising signal56

Responsible Use of Large Language Models in Microbial Genomics and Bioinformatics: A Life-Science Framework for Reliability, Reproducibility, and Risk-Aware Interpretation

Publication signal: Responsible Use of Large Language Models in Microbial Genomics and Bioinformatics: A Life-Science Framework for Reliability, Reproducibility, and Risk-Aware Interpretation

Verified by AIScieditor reviewed / 1 evidence source
Clinical and RegulatoryFoundation Models and Agents
1 evidence source
Source 1: Multidisciplinary Digital Publishing Institute
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Tracked signal53

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

Clinical/translation signal: A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Clinical and Regulatory
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context